Table 1

Observed and expected deaths for all men and women

Site (ICD-7 code)ObservedExpectedObs/Exp (95% CI)
All neoplasms (140–239)537221.582.42 (2.22 to 2.64)
Buccal cavity and pharynx (140–148)53.241.54 (0.50 to 3.60)
Oesophagus (150)125.782.08 (1.07 to 3.63)
Stomach (151)2823.091.21 (0.81 to 1.75)
Small intestines (152)20.464.33 (0.52 to 15.6)
Colon (153)2714.781.83 (1.20 to 2.66)
Rectum (154)1010.100.99 (0.47 to 1.82)
Liver, gall and bile ducts (155–156)103.762.66 (1.28 to 4.89)
Pancreas (157)89.260.86 (0.37 to 1.70)
Larynx (161)31.841.63 (0.34 to 4.76)
Lung (162–163, 231)23276.963.01 (2.64 to 3.43)
Breast (170)1210.481.15 (0.59 to 2.00)
Uterus-cervix (171)62.702.22 (0.81 to 4.83)
Uterus-other, and unspecified (172, 174)01.280.00 (0.00 to 2.87)
Ovary (175)93.562.53 (1.16 to 4.80)
Prostate (177)57.140.70 (0.23 to 1.63)
Testis (178)10.821.22 (0.03 to 6.79)
Kidney (180)23.640.55 (0.07 to 1.99)
Bladder (181)106.911.45 (0.69 to 2.66)
Melanoma (190)01.390.00 (0.00 to 2.65)
Skin-other (191)00.690.00 (0.00 to 5.35)
Brain and CNS (193, 223, 237)87.661.04 (0.45 to 2.06)
Thyroid (194)00.550.00 (0.00 to 6.65)
Bone (196)00.890.00 (0.00 to 4.14)
Soft tissue (197)00.600.00 (0.00 to 6.10)
Hodgkin's disease (201)22.140.93 (0.11 to 3.37)
Myeloma (203)32.131.41 (0.29 to 4.12)
Leukaemia (204)75.291.32 (0.53 to 2.72)
Other lymphoma (200, 202)43.611.11 (0.30 to 2.84)
Mesothelioma-pleural52 61 (46 to 80)1-150
Mesothelioma-peritoneal46 54 (40 to 72)1-150
Other sites3310.81
  • 1-150 Rate per 100 000 person-years